Interactions Between Gut Microbiota and Acute Childhood Leukemia

Area of Science:

• Microbiology
• Oncology
• Pediatrics

Background:

• Childhood leukemia, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), is the most common childhood cancer.
• Despite improved survival rates, long-term health issues and risk factors for childhood leukemia require further investigation.
• The gut microbiota, a complex community of microorganisms, plays a role in host metabolism and immune regulation, and is increasingly linked to various diseases.

Purpose of the Study:

• To review the role of gut microbiota in the onset, progression, and prognosis of acute childhood leukemia.
• To examine how leukemia treatments impact the gut microbiota.
• To explore dietary strategies for modulating gut microbiota to aid in childhood leukemia management.

Main Methods:

• Literature review of studies investigating the gut microbiome and childhood leukemia.
• Analysis of existing research on microbiota's role in cancer development and immune function.
• Synthesis of findings on the impact of leukemia therapies on gut microbial composition.

Main Results:

• Emerging evidence suggests a significant association between gut microbiota composition and the risk and progression of childhood leukemia.
• Leukemia treatments, such as chemotherapy, can profoundly alter gut microbial diversity and function.
• Dietary interventions show potential for influencing gut microbiota profiles relevant to leukemia.

Conclusions:

• The gut microbiota is implicated in the pathogenesis and progression of childhood leukemia.
• Understanding these microbial interactions is crucial for developing novel prevention and treatment strategies.
• Targeting the gut microbiome through dietary adjustments offers a promising avenue for improving outcomes in childhood leukemia survivors.